Fintel reports that on December 11, 2024, Jefferies upgraded their outlook for ICU Medical (NasdaqGS:ICUI) from Hold to Buy.
Analyst Price Forecast Suggests 28.13% Upside
As of December 3, 2024, the average one-year price target for ICU Medical is $212.77/share. The forecasts range from a low of $202.00 to a high of $236.25. The average price target represents an increase of 28.13% from its latest reported closing price of $166.06 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for ICU Medical is 2,544MM, an increase of 8.71%. The projected annual non-GAAP EPS is 10.05.
What is the Fund Sentiment?
There are 636 funds or institutions reporting positions in ICU Medical. This is an increase of 80 owner(s) or 14.39% in the last quarter. Average portfolio weight of all funds dedicated to ICUI is 0.20%, an increase of 22.54%. Total shares owned by institutions increased in the last three months by 12.50% to 33,904K shares. 
The put/call ratio of ICUI is 1.67, indicating a bearish outlook.
What are Other Shareholders Doing?
Janus Henderson Group holds 2,412K shares representing 9.85% ownership of the company. In its prior filing, the firm reported owning 2,444K shares , representing a decrease of 1.33%. The firm decreased its portfolio allocation in ICUI by 49.75% over the last quarter.
IJR - iShares Core S&P Small-Cap ETF holds 1,552K shares representing 6.34% ownership of the company. In its prior filing, the firm reported owning 1,324K shares , representing an increase of 14.73%. The firm increased its portfolio allocation in ICUI by 61.48% over the last quarter.
Fuller & Thaler Asset Management holds 1,413K shares representing 5.77% ownership of the company. In its prior filing, the firm reported owning 1,519K shares , representing a decrease of 7.54%. The firm increased its portfolio allocation in ICUI by 30.82% over the last quarter.
JAENX - Janus Henderson Enterprise Fund Class T holds 1,231K shares representing 5.03% ownership of the company. No change in the last quarter.
UBVLX - Undiscovered Managers Behavioral Value Fund Class L holds 1,216K shares representing 4.97% ownership of the company. In its prior filing, the firm reported owning 1,285K shares , representing a decrease of 5.67%. The firm increased its portfolio allocation in ICUI by 29.84% over the last quarter.
ICU Medical Background Information
(This description is provided by the company.)
ICU Medical, Inc. develops, manufactures and sells innovative medical products used in infusion therapy and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. ICU Medical is headquartered in San Clemente, California.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
